HIKAL / NSE / Biotechnology & Drugs
Hikal
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High386.55
Target Low145.95
Target Mean1
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk49.81
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Hikal opens special window for physical share transfer until February 2027 scanx.trade
HIKAL LIMITED Share Price Today - Live HIKAL Stock Price for NSE/BSE Upstox
Hikal Limited seeks shareholder nod for Independent Director appointment scanx.trade
Hikal to announce Quarterly Result Capital Market
Hikal FY26 net loss of ₹49 crore on exceptional items scanx.trade
Hikal Consolidated March 2026 Net Sales at Rs 519.40 crore, down 5.97% Y-o-Y Moneycontrol.com
Hikal Consolidated March 2026 Net Sales at Rs 519.40 crore, down 5.97% Y-o-Y Moneycontrol.com
Hikal Ltd is Rated Strong Sell Markets Mojo
© SharekeyX | Rusaka Technologies 2024-2026

